Impact of a mHealth Intervention in Type 2 Diabetes Mellitus Patients: A Randomized Clinical Trial

Farazul Hoda,Mawrah Arshad,Mohammad Ahmed Khan,Sunil Kohli,Shahid Kareem,Mohd Akhtar,Abul Kalam Najmi

DOI: https://doi.org/10.1007/s42399-023-01564-3

2023-09-07

SN Comprehensive Clinical Medicine

Abstract:To evaluate the impact of mHealth (Mobile Health) intervention on glycaemic control and secondary outcomes in patients with Type 2 Diabetes Mellitus (T2DM). This was a 3 month open-label randomized control parallel arm study. The study was conducted in the outpatient department of Hakeem Abdul Hameed Centenary Hospital, Jamia Hamdard, New Delhi. 100 participants with Type 2 Diabetes Mellitus patients ( n = 50 intervention, n = 50 control). Intervention group received (routine diabetes care + 3–5 messages and a call every week) and control group (routine diabetes care). Messages and calls were delivered by a trained pharmacist through mobile phone manually. The primary outcome measure was change in HbA1c (Glycated Haemoglobin) at baseline and at the end of the follow-up after 3 months. 100 patients with T2DM were randomized to the intervention and control groups ( n = 50). HbA1c level decreased by 0.95% in the intervention group compared with 0.48% in the controls (0.59; 95% confidence interval [CI] –0.27 to 1.17) at 6 months. ( p < 0.01) ( p < 0.046). Secondary outcomes such as medication compliance, eating habits, physical activity, and HRQoL were also found significant in the intervention of mhealth. The study supports mHealth interventions and may improve glycemic control and secondary outcomes in T2DM patients. However, further research and evidence are needed before widespread clinical implementation can be considered.